Literature DB >> 16732693

Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults.

Shelly A Vik1, David B Hogan, Scott B Patten, Jeffrey A Johnson, Lori Romonko-Slack, Colleen J Maxwell.   

Abstract

BACKGROUND: Despite a higher risk for medication nonadherence among older adults residing in the community, few prospective studies have investigated the health outcomes associated with nonadherence in this population or the possible variations in risk in urban versus rural residents.
OBJECTIVES: The primary objective of this study was to examine, in a prospective manner, the risk for hospitalisation (including an emergency department visit) and/or mortality associated with medication nonadherence in older, at-risk adults residing in the community. A secondary objective was to examine differences in the prevalence, determinants and consequences of medication nonadherence between rural and urban home care clients.
METHODS: Data were derived from a 1-year prospective study of home care clients aged > or =65 years (n = 319) randomly selected from urban and rural settings in southern Alberta, Canada. Trained nurses conducted in-home assessments including a comprehensive medication review, self-report measures of adherence and the Minimum Data Set for Home Care (MDS-HC) tool. Hospitalisation and mortality data during 12-month follow-up were obtained via linkages with regional administrative and vital statistics databases.
RESULTS: Nonadherent clients showed an increased but nonsignificant risk for an adverse health outcome (hospitalisation, emergency department visit or death) during follow-up (hazard ratio [adjusted for relevant covariates] = 1.24, 95% CI 0.93, 1.65). Subgroup analyses suggested this risk may be higher for unintentional nonadherence (unadjusted hazard ratio = 1.55, 95% CI 0.97, 2.48). The prevalence of nonadherence was similar among rural (38.2%) and urban (38.9%) clients and was associated with the presence of vision problems, a history of smoking, depressive symptoms, a high drug regimen complexity score, residence in a private home (vs assisted-living setting) and absence of assistance with medication administration. In both settings, approximately 20% of clients received one or more inappropriate medications.
CONCLUSIONS: Although not associated with rural/urban residence, medication nonadherence was common in our study population, particularly among those with depressive symptoms and complex medication regimens. The absence of a significant association between overall medication nonadherence and health outcomes may reflect study limitations and/or the need to differentiate among types of nonadherent behaviours.

Entities:  

Mesh:

Year:  2006        PMID: 16732693     DOI: 10.2165/00002512-200623040-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  47 in total

1.  The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs.

Authors:  S J Billups; D C Malone; B L Carter
Journal:  Pharmacotherapy       Date:  2000-08       Impact factor: 4.705

2.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

3.  Predictors of medication noncompliance in a sample of older adults.

Authors:  S J Coons; S L Sheahan; S S Martin; J Hendricks; C A Robbins; J A Johnson
Journal:  Clin Ther       Date:  1994 Jan-Feb       Impact factor: 3.393

4.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

5.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

Authors:  H A Llewellyn-Thomas; M J McGreal; E C Thiel; S Fine; C Erlichman
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

6.  Self-reported memory of medication use by the elderly.

Authors:  M V Spiers; D M Kutzik
Journal:  Am J Health Syst Pharm       Date:  1995-05-01       Impact factor: 2.637

7.  The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people.

Authors:  John P Hirdes; Dinnus H Frijters; Gary F Teare
Journal:  J Am Geriatr Soc       Date:  2003-01       Impact factor: 5.562

8.  Can medication education improve the drug compliance of the elderly? Evaluation of an in hospital program.

Authors:  P Hawe; G Higgins
Journal:  Patient Educ Couns       Date:  1990-10

9.  Screening for noncompliance among patients with hypertension: is self-report the best available measure?

Authors:  T S Inui; W B Carter; R E Pecoraro
Journal:  Med Care       Date:  1981-10       Impact factor: 2.983

10.  Major depression and medication adherence in elderly patients with coronary artery disease.

Authors:  R M Carney; K E Freedland; S A Eisen; M W Rich; A S Jaffe
Journal:  Health Psychol       Date:  1995-01       Impact factor: 4.267

View more
  24 in total

Review 1.  Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.

Authors:  Laís Lessa Pantuzza; Maria das Graças Braga Ceccato; Micheline Rosa Silveira; Luane Mendes Ribeiro Junqueira; Adriano Max Moreira Reis
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

2.  Risk factors for medication misadventure among residents in sheltered housing complexes.

Authors:  Johnson George; Kim Munro; Dorothy McCaig; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

Review 3.  [Adherence to neurologic treatment. Lessons from multiple sclerosis].

Authors:  S Kern; H Reichmann; T Ziemssen
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

Review 4.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

Review 5.  Comparative studies of how living circumstances influence medication adherence in ≥65 year olds.

Authors:  Sheila A Doggrell; Therése Kairuz
Journal:  Int J Clin Pharm       Date:  2013-12-07

6.  The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis.

Authors:  Caroline A Walsh; Caitriona Cahir; Sarah Tecklenborg; Catherine Byrne; Michael A Culbertson; Kathleen E Bennett
Journal:  Br J Clin Pharmacol       Date:  2019-09-06       Impact factor: 4.335

7.  Association between adherence to antihypertensive medications and health outcomes in middle and older aged community dwelling adults; results from the Irish longitudinal study on ageing.

Authors:  Caroline A Walsh; Caitriona Cahir; Kathleen E Bennett
Journal:  Eur J Clin Pharmacol       Date:  2019-06-12       Impact factor: 2.953

8.  Adherence to alendronate in male veterans.

Authors:  K E Hansen; E D Swenson; B Baltz; A A Schuna; A N Jones; M E Elliott
Journal:  Osteoporos Int       Date:  2007-09-26       Impact factor: 4.507

Review 9.  A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications.

Authors:  Johnson George; Rohan A Elliott; Derek C Stewart
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.

Authors:  F-E Cotté; P Fardellone; F Mercier; A-F Gaudin; C Roux
Journal:  Osteoporos Int       Date:  2009-05-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.